There were 1,951 press releases posted in the last 24 hours and 443,048 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AB Science receives Notice of Deficiency (NOD) from Health Canada for masitinib in the treatment of amyotrophic lateral sclerosis (ALS)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image